Pharvaris N.V. (PHVS)
NASDAQ·Healthcare·Biotechnology
$32.39
+1.78%
Mkt Cap $2.19B
Analyst Ratings
Buy
12
Hold
0
Sell
0
Price Target (27 analysts)
$60.75
Range $42.00 – $79.00
Implied Upside
+87.6%
Consensus $60.75 vs current $32.39
NASDAQ·Healthcare·Biotechnology
$32.39
+1.78%
Mkt Cap $2.19B
Buy
12
Hold
0
Sell
0
Price Target (27 analysts)
$60.75
Range $42.00 – $79.00
+87.6%
Consensus $60.75 vs current $32.39